Data from a comparative study found liraglutide and dulaglutide presented similar effectiveness as semaglutide in the ...

• For $94, you can get a malnourished child access to a highly effective treatment program. For $1,500 to $4,500, you can ...

Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...

Adia Nutrition Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine through its subsidiary Adia Med, today ...

Patients treated with transcutaneous auricular vagus nerve stimulation showed a significant reduction in facial erythema ...

Trial to assess cadisegliatin as potential adjunctive therapy to insulin in patients with T2DHIGH POINT, N.C., Dec. 18, 2025 ...

Background Inflammatory bowel disease (IBD) patients in China exhibit critically low levels of physical activity, yet evidence for telemedicine-based aerobic exercise interventions remains scarce, ...

Background Although multiple studies have offered self-collection for human papillomavirus (HPV)-based cervical screening in ...

Why lasting weight maintenance requires more than calorie control, integrating diet quality, movement, circadian biology, ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Texas allocates $50 million to UT-led IMPACT partnership for ibogaine clinical trials treating PTSD, addiction, and more.

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...